ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $16,355,000 | +228.4% | 175,976 | +110.4% | 0.53% | +228.8% |
Q3 2021 | $4,980,000 | -62.8% | 83,629 | -57.4% | 0.16% | -63.2% |
Q2 2021 | $13,393,000 | -1.7% | 196,385 | 0.0% | 0.44% | -7.2% |
Q1 2021 | $13,627,000 | -29.9% | 196,385 | -22.4% | 0.47% | -31.3% |
Q4 2020 | $19,436,000 | +61.8% | 252,971 | +57.5% | 0.68% | +51.8% |
Q3 2020 | $12,014,000 | +116.9% | 160,637 | +82.5% | 0.45% | +113.3% |
Q2 2020 | $5,540,000 | +371.1% | 88,002 | +214.3% | 0.21% | +298.1% |
Q1 2020 | $1,176,000 | -7.5% | 28,002 | 0.0% | 0.05% | +10.4% |
Q4 2019 | $1,272,000 | -0.8% | 28,002 | 0.0% | 0.05% | -14.3% |
Q3 2019 | $1,282,000 | -21.9% | 28,002 | 0.0% | 0.06% | -16.4% |
Q2 2019 | $1,642,000 | -29.9% | 28,002 | -46.4% | 0.07% | -29.5% |
Q1 2019 | $2,343,000 | +15.1% | 52,262 | 0.0% | 0.10% | +9.2% |
Q4 2018 | $2,036,000 | -52.8% | 52,262 | -44.3% | 0.09% | -44.2% |
Q3 2018 | $4,315,000 | +5.6% | 93,767 | 0.0% | 0.16% | +0.6% |
Q2 2018 | $4,088,000 | +514.7% | 93,767 | +457.2% | 0.16% | +496.2% |
Q1 2018 | $665,000 | – | 16,827 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |